SCHEMBL6593295

SCHEMBL6593295

Nc1cc(F)ccc1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 3/20 0.58
RAB9A P51151 4/20 0.58
NPC1 O15118 3/20 0.58
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
KMT2A Q03164 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
FADS1 O60427 4/20 0.57
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
HDAC1 Q13547 1/20 0.51
PYGL P06737 1/20 0.51
PNLIP P16233 1/20 0.51
F10 P00742 1/20 0.50
SNCA P37840 1/20 0.49
GRIK1 P39086 1/20 0.48
KLKB1 P03952 1/20 0.48
P2RX4 Q99571 1/20 0.48
P2RX7 Q99572 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6594140 0.88 FADS1 (0.72) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL10430505 0.84 FADS1 (0.56) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL6590611 0.83 NPC1 (0.58) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL3157389 0.83 RAB9A (0.62) RAB9ANPC1ALDH1A1LMNAKMT2A
SCHEMBL15920940 0.82 KMT2A (0.69) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL17142908 0.82 JAK2 (0.61) P2RX1RAB9ALMNAKMT2AFADS1
SCHEMBL5221079 0.81 NPC1 (0.54) RAB9ANPC1KMT2ASMN1; SMN2HTT
SCHEMBL6593129 0.81 FADS1 (0.60) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL5534714 0.81 PRSS12 (0.54) P2RX1RAB9ANPC1ALDH1A1LMNA
SCHEMBL17343031 0.79 EPHX2 (0.54) RAB9ANPC1KMT2ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed